This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1978:29:367-78.

doi: 10.1146/annurev.me.29.020178.002055.

Heparin, antithrombin, and abnormal clotting

PMID: 77142
DOI: 10.1146/annurev.me.29.020178.002055

Review

Heparin, antithrombin, and abnormal clotting

R D Rosenberg. Annu Rev Med. 1978.

. 1978:29:367-78.

doi: 10.1146/annurev.me.29.020178.002055.

Author

PMID: 77142
DOI: 10.1146/annurev.me.29.020178.002055

No abstract available

PubMed Disclaimer

Similar articles

Actions and interactions of antithrombin and heparin.
Rosenberg RD. Rosenberg RD. N Engl J Med. 1975 Jan 16;292(3):146-51. doi: 10.1056/NEJM197501162920307. N Engl J Med. 1975. PMID: 127943 Review. No abstract available.
Studies on the mechanism of heparin action by modification of its structure.
Danishefsky I. Danishefsky I. Fed Proc. 1977 Jan;36(1):33-5. Fed Proc. 1977. PMID: 830555 No abstract available.
Chemistry of heparin and low molecular weight heparin.
Nielsen JI, Ostergaard P. Nielsen JI, et al. Acta Chir Scand Suppl. 1988;543:52-6. Acta Chir Scand Suppl. 1988. PMID: 2847458 Review. No abstract available.
Inhibition of thrombin-induced aggregation of human platelets by heparin and antithrombin 3.
Eika C. Eika C. Scand J Haematol. 1971;8(4):250-6. doi: 10.1111/j.1600-0609.1971.tb00872.x. Scand J Haematol. 1971. PMID: 5134471 No abstract available.
Molecular weight of heparin versus biologic activity. Some additional considerations.
Losito R, Losito C. Losito R, et al. Semin Thromb Hemost. 1985 Jan;11(1):29-33. doi: 10.1055/s-2007-1004355. Semin Thromb Hemost. 1985. PMID: 2579437 Review. No abstract available.

See all similar articles

Cited by

Anticoagulation management during veno-venous ECMO support because of ARDS: Single-center experience.
Kuzmin B, Wacker M, Ponomarenko J, Movsisyan A, Praetsch F, Marsch G, Keyser O, Fadel M, Scherner M, Wippermann J. Kuzmin B, et al. Heliyon. 2024 Nov 14;10(22):e40417. doi: 10.1016/j.heliyon.2024.e40417. eCollection 2024 Nov 30. Heliyon. 2024. PMID: 39634389 Free PMC article.
Heparin 1986. Indications and effective use.
Ockelford P. Ockelford P. Drugs. 1986 Jan;31(1):81-92. doi: 10.2165/00003495-198631010-00007. Drugs. 1986. PMID: 3510115 Clinical Trial.
Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.
Douaiher J, Succar J, Lancerotto L, Gurish MF, Orgill DP, Hamilton MJ, Krilis SA, Stevens RL. Douaiher J, et al. Adv Immunol. 2014;122:211-52. doi: 10.1016/B978-0-12-800267-4.00006-7. Adv Immunol. 2014. PMID: 24507159 Free PMC article. Review.
Clinical pharmacokinetics of heparin.
Estes JW. Estes JW. Clin Pharmacokinet. 1980 May-Jun;5(3):204-20. doi: 10.2165/00003088-198005030-00002. Clin Pharmacokinet. 1980. PMID: 6993082 Review.
Evidence for antithrombin III involvement in the anticoagulant activity of cellulose sulphate.
Kindness G, Long WF, Williamson FB. Kindness G, et al. Br J Pharmacol. 1980 Apr;68(4):645-9. doi: 10.1111/j.1476-5381.1980.tb10856.x. Br J Pharmacol. 1980. PMID: 7378640 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ingenta plc